|
|
|
| The biotechnology sector is transforming with AI, automation, and digitalization playing key roles in drug development and manufacturing. As the industry moves toward end-to-end digitalization, don't miss the opportunity to join the 2025 ISPE Biotechnology Conference, 2 – 3 June in Boston, Massachusetts, USA, and virtually, to gain a holistic perspective on how to view and apply digital transformation in biopharmaceutical manufacturing. Register today |
|
|
|
| GMP Annex 1 For Sterile Manufacturing In The EU | Infographic | Jubilant HollisterStier | The revised EU GMP Annex 1 mandates a comprehensive Contamination Control Strategy, continuous environmental monitoring, and species-level contaminant identification to ensure compliance. |
|
|
|
|
| Bypassing The Challenges Of Paper-Based Validation | Case Study | ValGenesis | Delve into why a biotechnology startup and CDMO views investment in a digitized validation lifecycle management system as crucial for accelerating innovation and reducing time to market. |
|
|
|
|
|
| Getting More From Your Buffer Management Strategy | Case Study | Asahi Kasei Bioprocess | A drug manufacturer was facing challenges in buffer management. By implementing innovative inline buffer formulation technology, they were able to save space and increase efficiency. |
|
|
| Use High-Content Imaging To Drive Small Molecule Protein Degraders | Poster | By Clark Driscoll, Erin Olin, Adam McCabe, Nicholas Lenhard, Jennie Sims, Ph.D., and Gregory Williams, Ph.D., Curia | Find out how a cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system efficiently identifies small molecule protein degraders with multi-dimensional data. |
|
|
|
|
|
|
|
By Michiel Stam, MAIN5 | ISO Identification of Medicinal Products (IDMP) standards were designed to harmonize the way the life sciences industry records and manages data about its products. Companies’ state of readiness to implement and harness IDMP still varies. | |
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|